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Background
The restoration of coronary flow by transluminal coronary angioplasty has dramatically improved the prognosis of STEMI [1] . However, the positive impact of advances in the quality of PCI has been limited by the persistence of coronary microcirculatory obstructive injuries that jeopardize optimal myocardial reperfusion.
MO injuries that develop during an acute myocardial infarction have been described as the ''no-reflow'' phenomenon, which remains a frequent, yet underestimated, complication during STEMI [2] [3] [4] . MO lesions are associated with poor outcome in patients undergoing PCI, with increased rates of adverse cardiovascular events and an enhanced LV remodelling process [4] [5] [6] [7] . The development of microcirculatory injuries after PCI depends on multiple factors, including ischaemic and reperfusion injuries, but its precise pathophysiology remains partially unknown [8, 9] . Early detection of MO after PCI is still challenging, but it might help clinicians to identify patients at higher risk for complications [2] .
Angiographic variables such as TIMI flow frame count or myocardial blush assessment provide partial information about quality of microcirculatory perfusion [10] . ST-segment elevation resolution has been strongly correlated with outcome after MI but has not been specifically evalu-ated for microcirculatory injury detection [11] . Previous groups reported the successful use of myocardial contrast echocardiography [5, 12] or intracoronary flow Doppler assessment/index of microcirculatory resistance [13] to predict MO lesions. However, these latter methods might require specific devices and/or highly trained teams. Thus, physicians still need simple, accurate tools to promptly assess the success of reperfusion therapy in STEMI [2] .
The aim of this study was to analyse the clinical, electrical and angiographic factors associated with microcirculatory injuries, and to establish a bedside score for prediction of MO at the acute stage of STEMI, using CMR imaging as the standard of reference. Moreover, we aimed to assess the prognostic value of this MO score for prediction of clinical outcome during the first year after STEMI.
Materials and methods

Patient selection
STEMI was defined as chest pain that persisted for ≥ 30 minutes associated with ST-segment elevation ≥ 0.1 mV in at least two contiguous electrocardiographic leads [4] . Patients referred to our institution with STEMI, who underwent revascularization by primary or rescue PCI after thrombolysis failure, within the first 12 hours of evolution, were screened for inclusion. We excluded patients with cardiogenic shock, left bundle branch block on initial ECG, or severe chronic renal failure, and patients with contraindication to magnetic resonance imaging (claustrophobia, ferromagnetic foreign body, pacemaker, etc.).
Standard clinical and biological characteristics were assessed at baseline and creatine phosphokinase peak value was determined from consecutive blood sample measurements. Time to efficient revascularization (expressed in minutes) was calculated as the delay between onset of symptoms and completion of PCI. Overweight status was defined as a body mass index > 27 kg/m 2 . Creatinine clearance was calculated using the Cockroft-Gault method.
Our local ethics committee approved the study, which complied with the Declaration of Helsinki, and all patients gave their written consent before inclusion.
STEMI management
All patients included in the study were treated in accordance with international guidelines and the local protocols of our mobile care units [4] . Thrombolytic therapy was given to patients when PCI could not be achieved within 2 hours after first medical contact, using tenecteplase (0.5 mg/kg) unless contraindicated. Rescue PCI was proposed in case of thrombolysis failure, defined as persistence of chest pain and ST-segment elevation regression of < 50%, 90 minutes after tenecteplase bolus [4] .
Before catheterization, patients received aspirin 250 mg intravenously, a clopidogrel 300 mg bolus dose and an upstream abciximab loading dose (0.25 mg/kg of body weight), at the discretion of the physician. After coronary angiography, all patients (except those previously pretreated) received ad hoc abciximab as a 0.25 mg/kg bolus dose followed by a 12-hour infusion at 0.125 g/kg/min, unless contraindicated. Heparin (initial bolus dose of 70 U/kg) or enoxaparin (initial bolus dose of 1 mg/kg) were administered during the procedure to achieve adequate anticoagulation goals. Immediately after the procedure, a clopidogrel loading dose of up to 600 mg was completed. Patients were treated routinely with aspirin (325 mg/day) and clopidogrel (75 mg/day). Angiotensinconverting enzyme inhibitors, beta-blockers and statins were administered according to current international guidelines [4] . The culprit lesion was treated by stenting, that was performed directly, after balloon predilation or use of thrombectomy device, at the discretion of the operator. Preand post-PCI antegrade angiographic flows above the culprit lesion were reviewed retrospectively and classified according to the TIMI criteria by two operators who were unaware of the CMR results [14] .
Electrocardiographic analysis
Standard 12-lead ECGs were registered before, then 90 minutes and 24 hours after revascularization, using a speed of 25 mm/s and amplitude of 10 mm/mV. ST-segment elevation was measured manually at 60 ms after the J point in three successive QRS-T complexes in all the derivations, and the sum of the ST-segment elevation (ST sum ) was calculated. The value of the ST-segment elevation in the single lead with the most prominent deviation (ST max ) was also measured. The percentage of resolution of both variables was assessed 90 minutes and 24 hours after PCI.
CMR analysis
Between day 4 and day 8 after PCI, all included patients underwent CMR by two investigators who were unaware of the clinical, electrocardiographic and angiographic findings. All CMR studies were carried out using a 1.5 T wholebody magnetic resonance scanner (Symphony TIM, Siemens, Erlangen, Germany), with a 12-element surface coil. Images were acquired in end-inspiration breath-hold and under ECG gating.
Two CMR sequences were used, as follows. Cine sequences (steady-state free precession) were acquired in short axis for global function analysis with the following parameters: repetition time/echo time, 40/1.8 ms; slice thickness, 6 mm; no gap between slice; flip angle, 65 • ; field of view, 350 × 350 mm; matrix, 148 × 256; temporal resolution, 40 ms. Delayed enhancement (inversion-recovery gradient-echo) sequences were acquired 10 minutes after intravenous administration of Gd-DOTA 0.2 mmol/kg, encompassing the LV in short-axis, four-chamber and twochamber orientations. The sequences parameters were: repetition time/echo time, 780/1.56 ms; slice thickness, 6 mm; spacing, 0; flip angle, 10 • ; field of view, 350 × 400 cm; matrix, 152 × 134. The inversion time was 270-325 ms (set to null normal myocardial). End-diastolic phase was chosen to set the acquisition window.
All examinations were transferred to a computer workstation (Leonardo, Siemens, Erlanguen, Germany). Quantitative and qualitative analyses were performed by two independent observers blinded to other data. LV volumes (indexed to body surface area), LVEF and mass were measured according to Simpson's rule.
The presence and extent of myocardial infarction and MO were analysed qualitatively and quantitatively, using a 17-segment LV model. Myocardial infarction was defined on delayed contrast images as a hyperintense area in the LV myocardial wall supplied by the infarct-related artery. Myocardial necrosis extent was defined qualitatively as subendocardial (extent < 50% of whole wall thickness in more than half of the segments showing myocardial enhancement) or transmural (extent > 50% in more than half of the segments showing myocardial enhancement). MO was defined on delayed contrast enhanced images as a hypointense zone within the hyperenhanced infarcted zone [15] . The quantitative size of myocardial infarct and MO were computed by Simpson's method [15] . The extent of myocardial infarct and MO were expressed as a percentage of the total LV mass as follows: myocardial infarct extent (%) = (hyperenhanced area/LV area) × 100. MO extent (%) was computed as follows: hypoenhanced extent = (hypoenhanced area/LV area) × 100.
Follow-up
Clinical follow-up was carried out at clinical visits and/or through phone contact. We collected data prospectively regarding adverse cardiovascular events during the first year after STEMI. Cardiovascular adverse events were defined as cardiac death, acute congestive heart failure requiring hospital admission and intravenous infusion of diuretics, stroke, acute coronary syndrome and urgent PCI.
Statistical analysis
Statistical analysis was performed with SPSS 15.0 software for Windows (SPSS, Chicago, IL, USA). Data are expressed as mean and standard error of the mean and the normality of their distribution was assessed by the Kolmogorov-Smirnov test. Categorical and continuous variables were compared using the Chi 2 or Fisher's exact tests and Student's t test, respectively. Continuous variables were correlated using Pearson's coefficients.
For MO score estimation, we first performed univariate analysis to identify variables potentially associated with the presence of MO lesions. Next, we estimated the independent predictors of MO using a multivariable binary logistic regression analysis, including the different variables identified by the univariate analysis (˛= 0.25). Interactions between variables were introduced into the model to take the potential colinearities into account. Logistic regression was used to perform multivariable analysis and gain an estimation of the variables for the MO score (˛= 0.05). Finally, we designed an MO score based on this logistic model in which clinical relevant variables were balanced by a user-friendly coefficient.
For quality assessment, the MO score was first validated by the CART method, with cross-validation based on the jack-knife algorithm [16] . The CART methodology provides a hierarchical evaluation of prognostic variables. Firstly, it determines, for each variable, the cut-off values that optimize, in this instance, the identification of MO. Secondly, CART determines the optimal prognostic variable. This algorithm involves recursive subdivisions of a group of subjects on the basis of the choice of optimal cut-off points of the optimal prognostic variables, maximizing classical split criteria [17] . This method has been successfully applied in various clinical cardiovascular research studies [18] [19] [20] . We provided a cross-validation approach using the classical jack-knife algorithm [21, 22] . This sampling technique involves discarding one patient at a time and fitting a new model for the remaining patients (N-1), examining the score for its effectiveness in prediction.
Patients' classification after identification of MO lesions was used as a reference for receiver operating characteristic curve analysis. AUCs were compared using Hanley's method and z statistics.
Patient survival of events was analysed and Kaplan-Meier curves were constructed. Differences between survival curves were evaluated using the log-rank test. Cox proportional hazards regression was used to identify independent correlates of 1-year occurrence of adverse events (˛= 0.05).
Results
Baseline characteristics of the patients
Between January 2006 and August 2008, 165 patients with STEMI were admitted to our institution, 112 of who fulfilled the inclusion criteria ( Fig. 1 ). Baseline characteristics of the patients are displayed in Table 1 .
High incidence of MO lesions identified by CMR analysis
Microcirculatory injuries were identified in 63 (56%) patients. The incidence of MO lesions increased when the values of post-PCI TIMI flow and ST sum regression decreased ( Fig. 2) . Overall, the incidence of MO lesions was 45% in patients with a final TIMI 3 flow (n = 80), 82% in patients with a final TIMI < 3 flow (n = 32) and 42% in patients with 90-minute ST sum regression > 70% (n = 66).
Age, location of myocardial infarction and pharmacological management (Table 1) were identical in both groups. The clinical TIMI score and incidence of thrombolysis failure were higher in patients with MO injuries. Moreover, 9/10 patients with thrombolysis failure had MO lesions. The ischaemic time was longer and the creatine phosphokinase peak was higher in patients with MO injuries. Although the baseline angiographic TIMI flows were similar, the final mean TIMI flow was higher in patients without MO. As expected, the STsegment regression indices were superior in patients without MO lesions. Table 2 depicts CMR findings in the two groups of patients: transmural infarction extension was more frequent, infarct size was larger, LVEF was lower and LV end-systolic volume was higher in patients with MO. Finally, the incidence of pericardial effusion was higher in patients with STEMI complicated with microcirculatory injuries. Table 3 shows that time to efficient revascularization, TIMI final grade, thrombolysis failure and 90-minute ST sum regression were associated with the presence of microvascular injuries on CMR in the logistic regression multivariable anal- ysis. Moreover, we observed significant correlations between MO extent, 90-minute ST sum regression and TIMI final grade (Table 3) . A multiparametric score was built using coefficients designed for easy clinical practice (Table 4 ). Although thrombolysis failure was associated initially with MO lesions in the univariate analysis, it did not reach statistical significance in the multivariable model because of the lack of power of the variable, related to the lack of events (n = 10 thrombolysis failure). However, as this variable is highly clinically relevant, it was included in the score calculation.
Prediction of MO lesions with a multiparametric score
When classifying patients in the MO and no MO groups as a reference for the receiver operating characteristic curve (Fig. 3A) , the AUC was 0.87 ± 0.03 (p < 0.001). The optimal usable cut-off value of the score was > 4, with 84% sensitivity and 82% specificity for MO prediction (positive predictive value, 83%; negative predictive value, 79%). Similar results were observed in the specific subgroup of patients with final TIMI 3 flow: the AUC was 0.85 ± 0.04 (p < 0.001) with sensitivity of 78% and specificity of 88% for prediction of microvascular injuries.
Receiver operating characteristic analysis was applied to ST-regression variables, time to efficient revascularization and final TIMI grade variables ( Fig. 3B-D) . Although 90minute ST sum regression, 90-minute ST max regression, time to efficient revascularization and final TIMI grade correctly discriminated between patients with and without MO lesions, the MO score test was more accurate, with a larger AUC (p < 0.05 compared with previous variables; z statistics). Moreover, sensitivity and specificity were higher with the MO score than with ST-regression indices ( Table 5 ).
The MO score correlated significantly with infarct size (r = 0.36, p = 0.001) and MO extent (r = 0.48, p < 0.001), and correlated inversely with LVEF (r = -0.35, p < 0.001). Patients with MO score > 4 had a larger myocardial infarction zone (17.5 ± 1.2 vs 11.9 ± 1.4% LV, p = 0.003), lower LVEF (46.6 ± 1.4 vs 53.2 ± 1.6%, p = 0.003), larger end-diastolic LV volume (73.9 ± 2.4 vs 66.9 ± 2.4 mL/m 2 , p = 0.045) and larger endsystolic LV volume (38.6 ± 2.0 vs 31.4 ± 1.5 mL/m 2 , p = 0.005).
Predictors of MO lesions in univariable and multivariable models
Univariate analysis revealed that MO score > 4, final TIMI flow < 3, 90-minute ST sum regression < 50% and time to efficient revascularization > 200 minutes were associated with an increased frequency of microcirculatory injuries, whereas previous dyslipidaemia, three-vessel coronary artery disease and previous history of coronary artery disease were associated with a lower incidence of MO lesions.
Using the CART method with cross-validation, we compared two strategies: use of the MO score vs a combination of the other predictors of MO lesions. We observed that the MO score alone correctly identified 84% of the patients with MO (cross-validation), whereas the combination of the other predictors correctly identified only 76% of the patients.
Adverse clinical impact of high MO score value
Follow-up was achieved in 110 patients (two patients lost during follow-up) with a mean follow-up of 234 ± 12 days.
Patients with an MO score > 4 and patients with MO lesions on initial MRI (p = 0.004, not shown) had a significantly higher incidence of adverse cardiovascular events during the first year after STEMI (Fig. 4 ). Other predictors of adverse events are displayed in Table 6 . Multiple stepwise Cox regression analysis identified an MO score > 4 and clinical TIMI score as independent predictors of adverse cardiovascular events ( Table 6 ).
Discussion
The main findings of this study are that the incidence of MO lesions is high (56%) in a population of patients undergoing PCI for STEMI; that an MO score based on clinical, ECG and angiographic data predicted MO with an acceptable level of sensitivity and specificity; and that an MO score > 4 was an independent predictor of adverse cardiovascular events during the first year following STEMI. Development of MO injuries after PCI depends on various factors, including thrombus distal embolization, vasospasm, enhanced oxidative stress, neutrophile capillary plugging, myocardial oedema and inflammation [9] . However, the clinical and pharmacological factors associated with MO lesions remain partially unknown [9] and its real incidence varies according to its definition and the method chosen for assessment. Microcirculatory injuries were found in 25-30% of the patients in the studies using post-PCI TIMI flow measurement [23] and myocardial contrast echocardiography [24, 25] , but this percentage increased to 80% in series using post-PCI myocardial blush determination [26] . Fearon et al. reported recently a 52% incidence of MO lesions using microcirculatory resistance measurement [13] . Our results are consistent with the previous reports from groups using CMR [7, 27, 28] and microcirculatory resistance measurement [13] .
The methods currently available to detect MO (myocardial contrast echocardiography, intracoronary Doppler measurement, CMR) have some methodological limitations or might not be readily available in all cardiac catheterization facilities. Simple, inexpensive, bedside tools still might be useful to the cardiologist with no access to the above-mentioned techniques, who needs to assess quality of reperfusion after STEMI. We report here that a simple score based on clinical, ECG and angiographic findings is accurate in predicting MO lesion development. The MO score com-bines different types of information but is more sensitive and specific than each of these variables alone, as suggested by the CART analysis. Furthermore, our multivariable analysis shows that an MO score > 4 is a stronger predictor of MO than post-PCI TIMI grade or poor ST regression. As the MO score can be readily available in all catheterization laboratories and can be calculated in the first 90 minutes after PCI, our method fits with the goals of the international guide- lines that highlighted the need for a simple tool to predict microcirculatory injuries [2] . Many groups have previously reported the negative impact of microcirculatory injuries, identified on the basis of a binary approach (occurrence or no occurrence), on LV function in the short term, with an increased incidence of adverse cardiovascular events, and in the long term, with accelerated LV remodelling phenomenon and evolution towards congestive heart failure [5, 7, 27, 29, 30] . Our data are in line with these previous observations. The MO score provides clinical prognostic information after STEMI. This higher occurrence of clinical complications might be conferred by the larger extent of MI, MO lesions and lower LVEF observed in patients with an MO score > 4. Thus, the MO score appears to be a useful tool to promptly stratify and identify patients with a higher risk for clinical complications. These patients might benefit from more aggressive therapy, such as intra-aortic balloon counterpulsation [31] , or they might be suitable candidates for stem cell or growth factor therapy in the future [13] . Nevertheless, further studies are needed to evaluate these approaches.
Although our study has several strengths, we also recognize a number of limitations. Firstly, it is a single-centre study with a limited sample size. In addition, we excluded patients with cardiogenic shock and chronic renal failure from the analysis, thus focusing on those with low-tointermediate risk. The accuracy of the MO score in high-risk patients has yet to be confirmed. Moreover, the MO score was validated by internal cross-validation, according to CART methodology, and should be validated prospectively in an independent population of patients with STEMI. Finally, as our score includes analysis of the post-PCI TIMI flow grade, it cannot be applied to patients with successful thrombolysis who do not undergo emergency PCI.
In summary, the present study reports a high incidence of MO lesions after PCI for STEMI during the first 12 hours of evolution. MO lesions could be predicted with acceptable sensitivity and specificity using a multiparametric MO score based on clinical, ECG and angiographic data. An MO score > 4 is a strong independent predictor of microcirculatory lesions and adverse cardiovascular events at 1 year after STEMI. Further studies are needed to determine the prognostic value of this test by using it prospectively in a larger cohort of patients and studying its potential capacity to identify subgroups of patients that might benefit from more intensive therapy after MI.
